(Q36535642)

English

Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study

scientific article published on 22 November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Yumiko Nagao

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Takumi Kawaguchi

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Tatsuya Ide

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Michio Sata

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

publication date

22 November 2012

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Virology Journal

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

9

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

282

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

22 November 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1186/1743-422x-9-282

0 references

Branched-chain amino acids as pharmacological nutrients in chronic liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

30 September 2017

Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

30 September 2017

Serum albumin and mortality risk in a hyperendemic area of HCV infection in Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

30 September 2017

Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

30 September 2017

Ammonia metabolism, the brain and fatigue; revisiting the link.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

30 September 2017

Improvement of regional cerebral blood flow after oral intake of branched-chain amino acids in patients with cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

30 September 2017

Hepatocellular carcinoma: recent trends in Japan.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

30 September 2017

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

30 September 2017

Side effects of therapy for chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

30 September 2017

Side effects of therapy of hepatitis C and their management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

30 September 2017

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

30 September 2017

Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

30 September 2017

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

30 September 2017

Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

30 September 2017

Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

30 September 2017

A multicenter randomized controlled dose study of ursodeoxycholic acid for chronic hepatitis C

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

28 June 2018

Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-9-282

21 January 2018

The long term efficacy of glycyrrhizin in chronic hepatitis C patients.

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-9-282

21 January 2018

Efficacy of low dose long-term interferon monotherapy in aged patients with chronic hepatitis C genotype 1 and its relation to alpha-fetoprotein: A pilot study.

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-9-282

21 January 2018

Insulin resistance and lichen planus in patients with HCV-infectious liver diseases

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-9-282

21 January 2018

Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-9-282

21 January 2018

Aminofeel improves the sensitivity to taste in patients with HCV-infected liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

21 September 2018

Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

21 September 2018

Branched-chain amino acids improve insulin resistance in patients with hepatitis C virus-related liver disease: report of two cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

21 September 2018

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

21 September 2018

Anticatabolic effect of branched-chain amino acid-enriched solutions in patients with liver cirrhosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

21 September 2018

American Diabetes Association Resource Guide 2003. Blood glucose monitors and data management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545893

21 October 2018

Intravenous glycyrrhizin for the treatment of chronic hepatitis C: A double‐blind, randomized, placebo‐controlled phase I/II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23173649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23173649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

https://pubmed.ncbi.nlm.nih.gov/23173649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A decrease in AFP level related to administration of interferon in patients with chronic hepatitis C and a high level of AFP

1 reference

https://pubmed.ncbi.nlm.nih.gov/23173649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical benefits and cost-effectiveness of 17-year treatment with low-dose interferon-alpha 2b in a patient with chronic hepatitis C: a case report

1 reference

https://pubmed.ncbi.nlm.nih.gov/23173649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon therapy prolonged life expectancy among chronic hepatitis C patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23173649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1743-422X-9-282

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Dimensions Publication ID

0 references

release_vgreemfvs5fx5jqtdzadvpfe3q

1 reference

https://api.fatcat.wiki/v0/release/vgreemfvs5fx5jqtdzadvpfe3q

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36535642&oldid=1866161807"